The global nutrigenomics market is poised for exceptional growth, with projections indicating an increase from US$ 451.7 million in 2021 to an impressive US$ 2311.49 million by 2032. This robust expansion, marked by a remarkable compound annual growth rate (CAGR) of 16%, underscores the escalating demand for personalized nutrition solutions and the burgeoning awareness of health and wellness.
Key Market Drivers Fueling Growth
Rising Prevalence of Chronic Diseases: The surge in chronic conditions such as cardiovascular disorders, diabetes, and cancer is a significant catalyst for the nutrigenomics market. According to the World Health Organization (WHO), cardiovascular diseases claim approximately 17.9 million lives annually, making them the leading cause of death globally. Similarly, diabetes accounted for around 1.6 million deaths in 2016. This alarming rise in chronic diseases is driving the demand for nutrigenomics, which offers personalized dietary solutions to mitigate these health risks.
Personalized Nutrition for Athletes: The growing trend of personalized nutrition among athletes is another key driver. Tailored nutritional recommendations based on genetic profiles help optimize exercise performance, energy output, and overall health. This shift towards individualized dietary plans, away from a one-size-fits-all approach, is significantly boosting the nutrigenomics market. Athletes and fitness enthusiasts are increasingly adopting these personalized solutions to enhance their performance and achieve their health goals.
Consumer Awareness and Healthy Lifestyle Choices: The increasing consumer awareness of the benefits of healthy eating habits and functional foods is propelling the market forward. As more individuals recognize the role of nutrition in preventing chronic diseases and maintaining overall health, the demand for nutrigenomics is rising. Functional foods that have a positive physiological impact and delay the onset of chronic diseases are becoming more popular, further driving market growth.
Regional Insights and Opportunities
The nutrigenomics market in North America is expected to expand rapidly due to the high prevalence of obesity and diabetes. The Centers for Disease Control and Prevention (CDC) estimates that obesity will affect approximately 42% of the American population by 2030. This rising awareness of obesity-related health issues is expected to drive demand for customized nutritional products.
The Asia Pacific region presents significant growth opportunities for nutrigenomics service providers. Countries like India and Malaysia are grappling with high rates of diabetes and obesity. According to WHO, the number of people living with diabetes in India is expected to reach 79 million by 2030. In Southeast Asia, Malaysia has the highest prevalence of diabetes and obesity. This rising prevalence of chronic diseases in the region is expected to fuel market growth, making Asia Pacific a lucrative market for nutrigenomics.
Prominent Market Players
Leading companies in the global nutrigenomics market include Vitagene, Mapmygenome, Gini Health, geneOmbio, Nutrigenomix, 23andMe Inc., DNAfit, GX Sciences Inc., and Xcode Life. These key players are leveraging nutrigenomics to optimize nutritional intake, aiming to reduce the risk of diseases at all life stages. The increasing demand for healthy, personalized products is encouraging food manufacturers to incorporate nutrigenomics into their product development strategies, further driving market growth.
Recent Developments in the Nutrigenomics Market
- 23&Me and GlaxoSmithKline Partnership: In June 2018, 23&Me announced a partnership with GlaxoSmithKline to develop new treatments and potential cures using human genetics as a foundation.
- Global Genetic Project by 23&Me: Launched in February 2018, this project aims to enhance understanding of human genetic diversity and provide insights into health concerns affecting underrepresented populations.
- DNAFit and Vita Mojo Collaboration: In June 2017, DNAFit and Vita Mojo partnered to create the world’s most personalized restaurant menu, tailored to each customer’s DNA.
The nutrigenomics market is on a trajectory of significant growth, driven by the rising prevalence of chronic diseases, the increasing demand for personalized nutrition among athletes, and heightened consumer awareness of health and wellness. With key players continuously innovating and expanding their offerings, the market presents lucrative opportunities for investors. The shift towards personalized nutrition solutions is set to redefine dietary habits and health management, making nutrigenomics a promising and attractive investment avenue.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube